BCG Vaccination for Healthcare Workers: Who Should Consider It and Why?
Healthcare workers may come into contact with tuberculosis during clinical practice, but does that mean every doctor, nurse or healthcare professional should have a BCG vaccine?
In Australia, the answer is no.
BCG vaccination is not routinely recommended for all healthcare workers. However, it may be considered for healthcare professionals who have a high risk of exposure to tuberculosis, particularly drug-resistant tuberculosis.
Understanding who may benefit from BCG vaccination is important for healthcare workers preparing for overseas employment, humanitarian work, infectious disease placements or other high-risk clinical environments.
What is the BCG vaccine?
BCG stands for Bacille Calmette-Guerin. It is a live attenuated vaccine derived from Mycobacterium bovis and has been used to help protect against tuberculosis for more than a century.
Tuberculosis, commonly called TB, is caused by Mycobacterium tuberculosis.
TB most commonly affects the lungs, although it can also affect other organs. Infection can remain latent for years before becoming active disease.
The effectiveness of BCG vaccination varies according to age, population and the form of tuberculosis being considered.
Its protective effect is particularly important in young children, where BCG can substantially reduce the risk of severe forms of TB, including TB meningitis and miliary tuberculosis.
Protection in adults is less predictable.
Do Australian healthcare workers routinely need BCG vaccination?
No.
Australia is a low-incidence tuberculosis country. For most healthcare workers practising in Australia, BCG vaccination is not considered the primary method of occupational protection against TB.
Instead, TB prevention in healthcare settings relies heavily on:
- appropriate infection prevention and control
- respiratory protection where indicated
- occupational screening
- early identification of exposure
- testing for TB infection
- treatment of latent tuberculosis infection where appropriate
The Australian Immunisation Handbook advises that BCG vaccination may be considered for healthcare workers at high risk of exposure to drug-resistant tuberculosis, depending on individual circumstances and state or territory guidance.
This distinction is important.
Working in healthcare by itself does not automatically create an indication for BCG vaccination.
Which healthcare workers may benefit from BCG vaccination?
A clinical risk assessment may be appropriate for healthcare professionals who expect substantial occupational exposure to TB.
This can include healthcare workers planning to work overseas in countries or regions with a high incidence of tuberculosis, particularly where infection prevention measures may be limited.
Examples may include:
- doctors working in high-TB-incidence countries
- nurses undertaking overseas clinical placements
- healthcare workers involved in humanitarian programs
- medical professionals working with populations with a high prevalence of TB
- workers who may be exposed to multidrug-resistant TB
- some laboratory or clinical personnel with unusual occupational exposure risks
The decision should be individualised rather than based simply on job title.
Why is drug-resistant tuberculosis particularly important?
Drug-resistant TB presents a major clinical challenge because some of the medicines normally used to treat tuberculosis are no longer effective against the infecting organism.
Multidrug-resistant tuberculosis, often abbreviated as MDR-TB, is resistant to important first-line TB medicines.
More extensive resistance can make treatment longer, more complicated and potentially less successful.
For healthcare workers with a substantial risk of occupational exposure to drug-resistant TB, BCG vaccination may therefore form one part of a broader occupational health strategy.
It does not replace infection prevention and control.
What about healthcare workers travelling overseas?
This is one of the more important situations in which a healthcare worker may seek a BCG assessment.
A doctor, nurse, medical student or allied health professional preparing to work in a country with a high TB incidence may face a substantially different exposure environment from someone working in Australia.
Risk depends on factors including:
- destination
- local TB incidence
- duration of the placement
- type of healthcare facility
- patient population
- likelihood of treating people with active pulmonary TB
- prevalence of drug-resistant TB
- availability of appropriate respiratory protection
- quality of local infection control measures
The Australian Immunisation Handbook specifically identifies healthcare workers working overseas in high-TB-incidence settings as a group in whom the need for BCG vaccination should be assessed.
Is a Mantoux test required before BCG vaccination?
Not everyone automatically requires a tuberculin skin test before BCG vaccination.
The Australian Immunisation Handbook recommends assessing the person’s likelihood of previous tuberculosis exposure.
A tuberculin skin test, also called a TST or Mantoux test, may be indicated if the person:
- was born in a TB-endemic country
- has lived or travelled in a TB-endemic country or region
- has had close contact with someone with TB
- has had contact with someone being investigated for tuberculosis
Where pre-vaccination TST is indicated, the result helps determine whether BCG vaccination is appropriate or whether further investigation for latent or active TB is required.
This is one reason BCG vaccination should be approached as a clinical assessment rather than simply as a routine injection.
Can BCG vaccination interfere with future TB testing?
BCG vaccination can affect interpretation of the tuberculin skin test because the test measures an immune response to tuberculin.
For occupational screening, clinicians may also use an interferon-gamma release assay, commonly known as an IGRA, depending on the clinical circumstances and applicable guidelines.
Previous BCG vaccination should therefore be documented clearly in the person’s medical and occupational health records.
Is BCG vaccination effective in adults?
BCG provides its clearest protective benefit against severe tuberculosis in young children.
Protection against pulmonary TB in adults is more variable.
This is why Australian recommendations do not simply advise BCG vaccination for every healthcare worker.
The potential benefit needs to be considered against the person’s actual likelihood and type of TB exposure.
Is BCG a live vaccine?
Yes.
BCG is a live attenuated vaccine.
This has important implications because live vaccines are unsuitable for some people.
BCG vaccination is contraindicated in several circumstances, particularly significant immunocompromise. Pregnancy is also a contraindication to BCG vaccination under Australian recommendations.
A clinician should therefore assess medical history, medications, immune status, previous TB exposure and previous BCG vaccination before proceeding.
Does BCG replace masks and infection control?
No.
BCG vaccination should never be viewed as a substitute for appropriate occupational TB precautions.
Healthcare facilities caring for people with suspected or confirmed infectious TB need effective infection control systems.
Depending on the circumstances, these may include:
- early recognition of suspected TB
- appropriate patient isolation
- ventilation controls
- suitable respiratory protection
- staff education
- occupational TB screening
- post-exposure assessment
For healthcare workers, these measures remain central to TB prevention.
Do healthcare workers need BCG boosters?
Routine BCG revaccination is generally not recommended in Australia because there is insufficient evidence that additional doses provide meaningful extra protection.
A previous BCG scar or documented vaccination history should therefore be considered during assessment.
Planning overseas medical work?
Healthcare professionals preparing for overseas work should ideally consider TB risk before departure rather than immediately before travelling.
The assessment may include:
- previous BCG vaccination history
- previous TB exposure
- destination-specific TB risk
- occupational duties
- Mantoux testing where indicated
- contraindications to BCG
- timing of other live vaccines
- an individual discussion about the likely benefit of vaccination
Healthcare workers in Melbourne who require assessment can find information about local BCG vaccination services through the BCG Vaccination Melbourne clinic listing.
https://www.iseegp.com.au/listing/bcg-vaccination-melbourne-bcg-vaccine-clinic-book-online/
Key point for healthcare professionals
BCG vaccination is not a routine occupational vaccine for every Australian healthcare worker.
It is a targeted intervention.
Healthcare workers with substantial exposure to tuberculosis, particularly drug-resistant TB, or those preparing to work in high-incidence countries may benefit from individual assessment.
The decision should consider the person’s previous TB exposure, destination, occupational environment, immune status and the availability of effective infection control measures.
References
Australian Government Department of Health, Disability and Ageing. Vaccination for people at occupational risk. Updated 19 January 2026.
Australian Government Department of Health, Disability and Ageing. Immunisations for health care workers. Updated 18 June 2025.
World Health Organization. BCG vaccines: WHO position paper. Weekly Epidemiological Record. 2018.